DOCSLIB.ORG

Roberto Simone Phd Thesis 2008

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text

Load more

New approaches to unveil the Transcriptional landscape of dopaminergic neurons Roberto Simone International School for Advanced Studies PhD dissertation in Structural and Functional Genomics Trieste – October 2008 1 Supervisor: Prof. Stefano Gustincich, Ph.D. Neurobiology Sector The Giovanni Armenise-Harvard Laboratory SISSA - Trieste External Examiner: Dr Valerio Orlando, Ph.D. Epigenetics and Genome Reprogramming group Dulbecco Telethon Institute IGB CNR - Naples © Roberto Simone 2008 [email protected] Neurobiology Sector International School for Advanced Studies Trieste, Italy 2008 2 “La gente di solito usa le statistiche come un ubriaco i lampioni: più per sostegno che per illuminazione”. Mark Twain “L`insieme e` piu` della somma delle sue parti” Aristotele “La scienza della complessità` ci insegna che la complessita` che vediamo nel mondo e` il risultato di una semplicita` nascosta”. Chris Langton To my Parents: Cinzia and Giovanni, and to my sister Patrizia 3 Table of contents Abstract 9 List of abbreviations 10 SECTION 1. INTRODUCTION The complexity of the Eukaryotic Transcriptome The complexity of the Eukaryotic Transcriptome: Large part of the genome is transcribed 11 The complexity of the Eukaryotic Transcriptome: alternative splicing, alternative transcription initiation and termination 13 The dark side of the Eukaryotic Transcriptome –Transcripts of Unknown Function (TUF) 16 The complexity of the Eukaryotic Transcriptome: Poly A+ versus PolyA- transcripts 22 The complexity of the Eukaryotic Transcriptome: Nuclear versus cytoplasmic transcripts 25 The complexity of the Eukaryotic Transcriptome: What’s the function of many repeat elements? 29 The complexity of the Eukaryotic Transcriptome: S/AS pairs 32 The complexity of the Eukaryotic Transcriptome: the impact of the technical limitations on gene discovery and genome annotation 35 Technologies to unveil transcriptome complexity Technologies to unveil transcriptome complexity: cDNA microarrays, oligonucleotide Gene Chip and tiling arrays 39 Technologies to unveil transcriptome complexity: Serial Analysis of Gene Expression – SAGE 43 Technologies to unveil transcriptome complexity: Cap Analysis of Gene Expression – CAGE 45 Technologies to unveil transcriptome complexity: GIS, GSC, STAGE, DACS and other methods 49 Technologies to unveil transcriptome complexity: High-throughput sequencing technologies 51 Technologies to unveil transcriptome complexity: PCR-based and Transcription-based methods for RNA amplification 54 4 CAGE data and the analysis of mammalian promoters CAGE data and the analysis of mammalian promoters: The classical concept of “core promoter” 62 CAGE data and the analysis of mammalian promoters: Classification of promoter classes 65 CAGE data and the analysis of mammalian promoters: Transcription starts from unconventional sites (Exons, introns and 3`UTR) 67 CAGE data and the analysis of mammalian promoters: Widespread occurrence of alternative promoters 70 CAGE data and the analysis of mammalian promoters: Bidirectional promoters 78 CAGE data and the analysis of mammalian promoters: Mobile promoters 82 The multitasking genome- a new view for gene expression regulation and transcriptome structure 84 Then what is a gene? 92 Mesencephalic Dopaminergic Cells Mesencephalic Dopaminergic Cells: Overview of the system in mammals 95 Mesencephalic Dopaminergic Cells: Anatomical organization 96 Mesencephalic Dopaminergic Cells: Nigrostriatal and Mesolimbic-Mesocortical Pathways 99 Mesencephalic Dopaminergic Cells: The Basal Ganglia circuitry and mDA electrophysiological properties 102 Mesencephalic Dopaminergic Cells: Differentiation and Development 104 Mesencephalic Dopaminergic Cells: DAT, VMAT2 and COMT are crucial components of their function Dopamine Transporter (DAT): function, expression and regulation 110 DAT: multiple transcript isoforms 114 Vmat2: function, expression and regulation 115 Comt: function, expression and regulation 117 Comt: multiple transcript isoforms 118 Mesencephalic Dopaminergic Cells: previous gene expression studies 119 Mesencephalic Dopaminergic Cells: neuropsychiatric disorders 123 5 Parkinson`s disease Parkinson`s disease : retrospecitve, clinical features and epidemiology 127 Parkinson`s disease : Genetics 129 Parkinson`s disease : alpha-synuclein 131 Parkinson`s disease : multiple transcripts of Snca 137 Parkinson`s disease : molecular pathways 141 Parkinson`s disease : Current therapies 145 SECTION 2. MATERIALS AND METHODS Striatal Cells and RNA extraction 148 RNA amplification using SMART7 148 cDNA microarray: probe preparation, hybridizations and scanning 150 Statistical analysis of microarray data 151 Real Time-PCR of differentially expressed genes in Striatal cells 151 nanoCAGE –Illumina-Solexa 152 nanoCAGE – 454 154 Bioinformatic analysis of nanoCAGE data 157 RT-PCR Validation of target genes from total Midbrain 158 5`-RACE validation of target transcripts starting at specific TSSs 160 In Situ Hybridization (ISH) analysis of transcript isoforms on mice midbrain cryosections 161 Immunofluorescence (IF) 162 Oligonucleotide sequences and functional grouping 163 SECTION 3. RESULTS cDNA Microarray transcription profiling from limiting amount of starting material Overview and Validation of the SMART7 technique 165 6 Overview and Validation of the “Brownstein method” 169 SMART7 and cDNA microarrays 173 Developing of a new tecnique for Genome-Wide Tagging and Mapping of the Transcription Start Sites from limited amount of RNA: nanoCAGE and high- throughput sequencing The classical CAGE protocol requires micrograms of RNA 176 nanoCAGE – what is new: random priming, semi-suppressive PCR, starting from 10 ng 177 nanoCAGE-454 and nanoCAGE-Illumina-Solexa: new platforms for high-throughput gene expression profiling from small samples 181 Application of the NanoCAGE technology to the mesencephalic dopaminergic neurons SN (A9) and VTA (A10) dopaminergic nuclei LCM purification of A9 and A10 neurons and nanoCAGE amplification 181 Bioinformatic analysis of sequencing data 183 TSSs clustering strategies 187 Tag clusters-Transcripts associations 190 Generation of a list of potential target genes for further experimental validation 196 GO terms and categories distribution 198 Differentially expressed protein-coding transcripts in SN and VTA neurons 202 Chromosomal distribution of the promoters in SN and VTA neurons 204 Use of alternative promoters of biologically relevant protein coding genes in SN and VTA neurons Alpha-synuclein (Snca): Differential usage of alternative promoters potentially linked to different splicing patterns and post-transcriptional modifications of the protein 207 Dopamine Transporter (Slc6a3/Dat): Different alternative TSSs associated to potentially different protein isoforms 211 Vescicular Monoamine Transporter (Slc18a2): an alternative intronic TSS is mainly used by A10 neurons 212 Catechol-O-methyltransferase (Comt): alternative promoter usage associated to MB-Comt and S- Comt in A9 and A10 dopaminergic neurons 215 7 The non coding RNAs landscape in SN and VTA neurons as emerging from nanoCAGE and deep sequencing Relative abundance and different families of non coding RNAs 217 Differentially expressed microRNA transcripts in SN and VTA neurons 219 Sense-Antisense pairs transcription 220 Candidate non coding genes for establishing functional differences 222 SECTION 5. DISCUSSION and CONCLUSION 228 Acknowledgements 235 References 237 8 Abstract Recent advances in studying the mammalian transcriptome arised new questions about how genes are organized and what is the function of noncoding RNAs. Furthermore, the discovery of large amounts of polyA- transcripts and antisense transcription proved that a portion of the transcriptome has still to be characterized. The complex anatomo-functional organization of the brain has prevented a comprehensive analysis of the transcriptional landscape of this tissue. New techniques must be developed to approach neuronal heterogeneity. In this study we combined Laser Capture Microdissection (LCM) and nanoCAGE, based on Cap Analysis of Gene Expression (CAGE), to describe expressed genes and map their transcription start sites (TSS) in two specific populations, A9 and A10, of mouse mesencephalic dopaminergic cells. Although sharing common dopaminergic marker genes, these two populations are part of different midbrain anatomical structures, substantia nigra (SN) for A9 and ventral tegmental area (VTA) for A10, project to relatively distinct areas, participate to distinct ascending dopaminergic pathways, exhibit different electrophysiological properties and different susceptibility to neurodegeneration in Parkinson`s disease. Specific neurons were identified by the expression of Green Fluorescent Protein driven by a cell- type specific promoter in transgenic mice. High-quality RNAs were purified from 1000-2500 cells collected by LCM. We adapted the CAGE technique to analyze limiting amounts of RNAs (nanoCAGE). We took advantage of the cap-switching properties of the reverse transcriptase to specifically tag the 5`end of transcripts with a sequence containing a class III restriction site for EcoP15I. By creating 32bp 5`tags, we considerably improved the TSS mapping rate on the genome. A semi-suppressive PCR strategy was used to prevent primer dimers formation. The use of random priming in the 1st strand synthesis allowed to capture poly(A)- RNAs. 5`tags were sequenced with Illumina-Solexa platform. Here we show that this new nanoCAGE technology ensures a true high-throughput coverage
Recommended publications
  • Replace This with the Actual Title Using All Caps

    Replace This with the Actual Title Using All Caps

    UNDERSTANDING THE GENETICS UNDERLYING MASTITIS USING A MULTI-PRONGED APPROACH A Dissertation Presented to the Faculty of the Graduate School of Cornell University In Partial Fulfillment of the Requirements for the Degree of Doctor of Philosophy by Asha Marie Miles December 2019 © 2019 Asha Marie Miles UNDERSTANDING THE GENETICS UNDERLYING MASTITIS USING A MULTI-PRONGED APPROACH Asha Marie Miles, Ph. D. Cornell University 2019 This dissertation addresses deficiencies in the existing genetic characterization of mastitis due to granddaughter study designs and selection strategies based primarily on lactation average somatic cell score (SCS). Composite milk samples were collected across 6 sampling periods representing key lactation stages: 0-1 day in milk (DIM), 3- 5 DIM, 10-14 DIM, 50-60 DIM, 90-110 DIM, and 210-230 DIM. Cows were scored for front and rear teat length, width, end shape, and placement, fore udder attachment, udder cleft, udder depth, rear udder height, and rear udder width. Independent multivariable logistic regression models were used to generate odds ratios for elevated SCC (≥ 200,000 cells/ml) and farm-diagnosed clinical mastitis. Within our study cohort, loose fore udder attachment, flat teat ends, low rear udder height, and wide rear teats were associated with increased odds of mastitis. Principal component analysis was performed on these traits to create a single new phenotype describing mastitis susceptibility based on these high-risk phenotypes. Cows (N = 471) were genotyped on the Illumina BovineHD 777K SNP chip and considering all 14 traits of interest, a total of 56 genome-wide associations (GWA) were performed and 28 significantly associated quantitative trait loci (QTL) were identified.
  • Identification of Genes Concordantly Expressed with Atoh1 During Inner Ear Development

    Identification of Genes Concordantly Expressed with Atoh1 During Inner Ear Development

    Original Article doi: 10.5115/acb.2011.44.1.69 pISSN 2093-3665 eISSN 2093-3673 Identification of genes concordantly expressed with Atoh1 during inner ear development Heejei Yoon, Dong Jin Lee, Myoung Hee Kim, Jinwoong Bok Department of Anatomy, Brain Korea 21 Project for Medical Science, College of Medicine, Yonsei University, Seoul, Korea Abstract: The inner ear is composed of a cochlear duct and five vestibular organs in which mechanosensory hair cells play critical roles in receiving and relaying sound and balance signals to the brain. To identify novel genes associated with hair cell differentiation or function, we analyzed an archived gene expression dataset from embryonic mouse inner ear tissues. Since atonal homolog 1a (Atoh1) is a well known factor required for hair cell differentiation, we searched for genes expressed in a similar pattern with Atoh1 during inner ear development. The list from our analysis includes many genes previously reported to be involved in hair cell differentiation such as Myo6, Tecta, Myo7a, Cdh23, Atp6v1b1, and Gfi1. In addition, we identified many other genes that have not been associated with hair cell differentiation, including Tekt2, Spag6, Smpx, Lmod1, Myh7b, Kif9, Ttyh1, Scn11a and Cnga2. We examined expression patterns of some of the newly identified genes using real-time polymerase chain reaction and in situ hybridization. For example, Smpx and Tekt2, which are regulators for cytoskeletal dynamics, were shown specifically expressed in the hair cells, suggesting a possible role in hair cell differentiation or function. Here, by re- analyzing archived genetic profiling data, we identified a list of novel genes possibly involved in hair cell differentiation.
  • DOC2B (NM 003585) Human Tagged ORF Clone Product Data

    DOC2B (NM 003585) Human Tagged ORF Clone Product Data

    OriGene Technologies, Inc. 9620 Medical Center Drive, Ste 200 Rockville, MD 20850, US Phone: +1-888-267-4436 [email protected] EU: [email protected] CN: [email protected] Product datasheet for RC218949L2 DOC2B (NM_003585) Human Tagged ORF Clone Product data: Product Type: Expression Plasmids Product Name: DOC2B (NM_003585) Human Tagged ORF Clone Tag: mGFP Symbol: DOC2B Synonyms: DOC2BL Vector: pLenti-C-mGFP (PS100071) E. coli Selection: Chloramphenicol (34 ug/mL) Cell Selection: None ORF Nucleotide The ORF insert of this clone is exactly the same as(RC218949). Sequence: Restriction Sites: SgfI-MluI Cloning Scheme: ACCN: NM_003585 ORF Size: 1236 bp This product is to be used for laboratory only. Not for diagnostic or therapeutic use. View online » ©2021 OriGene Technologies, Inc., 9620 Medical Center Drive, Ste 200, Rockville, MD 20850, US 1 / 2 DOC2B (NM_003585) Human Tagged ORF Clone – RC218949L2 OTI Disclaimer: The molecular sequence of this clone aligns with the gene accession number as a point of reference only. However, individual transcript sequences of the same gene can differ through naturally occurring variations (e.g. polymorphisms), each with its own valid existence. This clone is substantially in agreement with the reference, but a complete review of all prevailing variants is recommended prior to use. More info OTI Annotation: This clone was engineered to express the complete ORF with an expression tag. Expression varies depending on the nature of the gene. RefSeq: NM_003585.1 RefSeq Size: 2030 bp RefSeq ORF: 1239 bp Locus ID: 8447 UniProt ID: Q14184 MW: 45.8 kDa Gene Summary: There are at least two protein isoforms of the Double C2 protein, namely alpha (DOC2A) and beta (DOC2B), which contain two C2-like domains.
  • Exploring the Relationship Between Gut Microbiota and Major Depressive Disorders

    Exploring the Relationship Between Gut Microbiota and Major Depressive Disorders

    E3S Web of Conferences 271, 03055 (2021) https://doi.org/10.1051/e3sconf/202127103055 ICEPE 2021 Exploring the Relationship between Gut Microbiota and Major Depressive Disorders Catherine Tian1 1Shanghai American School, Shanghai, China Abstract. Major Depressive Disorder (MDD) is a psychiatric disorder accompanied with a high rate of suicide, morbidity and mortality. With the symptom of an increasing or decreasing appetite, there is a possibility that MDD may have certain connections with gut microbiota, the colonies of microbes which reside in the human digestive system. In recent years, more and more studies started to demonstrate the links between MDD and gut microbiota from animal disease models and human metabolism studies. However, this relationship is still largely understudied, but it is very innovative since functional dissection of this relationship would furnish a new train of thought for more effective treatment of MDD. In this study, by using multiple genetic analytic tools including Allen Brain Atlas, genetic function analytical tools, and MicrobiomeAnalyst, I explored the genes that shows both expression in the brain and the digestive system to affirm that there is a connection between gut microbiota and the MDD. My approach finally identified 7 MDD genes likely to be associated with gut microbiota, implicating 3 molecular pathways: (1) Wnt Signaling, (2) citric acid cycle in the aerobic respiration, and (3) extracellular exosome signaling. These findings may shed light on new directions to understand the mechanism of MDD, potentially facilitating the development of probiotics for better psychiatric disorder treatment. 1 Introduction 1.1 Major Depressive Disorder Major Depressive Disorder (MDD) is a mood disorder that will affect the mood, behavior and other physical parts.
  • Human Induced Pluripotent Stem Cell–Derived Podocytes Mature Into Vascularized Glomeruli Upon Experimental Transplantation

    Human Induced Pluripotent Stem Cell–Derived Podocytes Mature Into Vascularized Glomeruli Upon Experimental Transplantation

    BASIC RESEARCH www.jasn.org Human Induced Pluripotent Stem Cell–Derived Podocytes Mature into Vascularized Glomeruli upon Experimental Transplantation † Sazia Sharmin,* Atsuhiro Taguchi,* Yusuke Kaku,* Yasuhiro Yoshimura,* Tomoko Ohmori,* ‡ † ‡ Tetsushi Sakuma, Masashi Mukoyama, Takashi Yamamoto, Hidetake Kurihara,§ and | Ryuichi Nishinakamura* *Department of Kidney Development, Institute of Molecular Embryology and Genetics, and †Department of Nephrology, Faculty of Life Sciences, Kumamoto University, Kumamoto, Japan; ‡Department of Mathematical and Life Sciences, Graduate School of Science, Hiroshima University, Hiroshima, Japan; §Division of Anatomy, Juntendo University School of Medicine, Tokyo, Japan; and |Japan Science and Technology Agency, CREST, Kumamoto, Japan ABSTRACT Glomerular podocytes express proteins, such as nephrin, that constitute the slit diaphragm, thereby contributing to the filtration process in the kidney. Glomerular development has been analyzed mainly in mice, whereas analysis of human kidney development has been minimal because of limited access to embryonic kidneys. We previously reported the induction of three-dimensional primordial glomeruli from human induced pluripotent stem (iPS) cells. Here, using transcription activator–like effector nuclease-mediated homologous recombination, we generated human iPS cell lines that express green fluorescent protein (GFP) in the NPHS1 locus, which encodes nephrin, and we show that GFP expression facilitated accurate visualization of nephrin-positive podocyte formation in
  • Identification of Biomarkers of Metastatic Disease in Uveal

    Identification of Biomarkers of Metastatic Disease in Uveal

    Identification of biomarkers of metastatic disease in uveal melanoma using proteomic analyses Thesis submitted in accordance with the requirements of the University of Liverpool for the degree of Doctor in Philosophy Martina Angi June 2015 To Mario, the wind beneath my wings 2 Acknowledgments First and foremost, I would like to acknowledge my primary supervisor, Prof. Sarah Coupland, for encouraging me to undergo a PhD and for supporting me in this long journey. I am truly grateful to Dr Helen Kalirai for being the person I could always turn to, for a word of advice on cell culture as much as on parenting skills. I would also like to acknowledge Prof. Bertil Damato for being an inspiration and a mentor; and Dr Sarah Lake and Dr Joseph Slupsky for their precious advice. I would like to thank Dawn, Haleh, Fidan and Fatima for becoming my family away from home, and the other members of the LOORG for the fruitful discussions and lovely cakes. I would like to acknowledge Prof. Heinrich Heimann and the clinical team at LOOC, especially Sisters Hebbar, Johnston, Hachuela and Kaye, for their admirable dedication to UM patients and for their invaluable support to clinical research. I would also like to thank the members of staff in St Paul’s theatre and Simon Biddolph and Anna Ikin in Pathology for their precious help in sample collection. I am grateful to Dr Rosalind Jenkins who guided my first steps in the mysterious word of proteomics, and to Dr Deb Simpsons and Prof. Rob Beynon for showing me its beauty.
  • Nº Ref Uniprot Proteína Péptidos Identificados Por MS/MS 1 P01024

    Nº Ref Uniprot Proteína Péptidos Identificados Por MS/MS 1 P01024

    Document downloaded from http://www.elsevier.es, day 26/09/2021. This copy is for personal use. Any transmission of this document by any media or format is strictly prohibited. Nº Ref Uniprot Proteína Péptidos identificados 1 P01024 CO3_HUMAN Complement C3 OS=Homo sapiens GN=C3 PE=1 SV=2 por 162MS/MS 2 P02751 FINC_HUMAN Fibronectin OS=Homo sapiens GN=FN1 PE=1 SV=4 131 3 P01023 A2MG_HUMAN Alpha-2-macroglobulin OS=Homo sapiens GN=A2M PE=1 SV=3 128 4 P0C0L4 CO4A_HUMAN Complement C4-A OS=Homo sapiens GN=C4A PE=1 SV=1 95 5 P04275 VWF_HUMAN von Willebrand factor OS=Homo sapiens GN=VWF PE=1 SV=4 81 6 P02675 FIBB_HUMAN Fibrinogen beta chain OS=Homo sapiens GN=FGB PE=1 SV=2 78 7 P01031 CO5_HUMAN Complement C5 OS=Homo sapiens GN=C5 PE=1 SV=4 66 8 P02768 ALBU_HUMAN Serum albumin OS=Homo sapiens GN=ALB PE=1 SV=2 66 9 P00450 CERU_HUMAN Ceruloplasmin OS=Homo sapiens GN=CP PE=1 SV=1 64 10 P02671 FIBA_HUMAN Fibrinogen alpha chain OS=Homo sapiens GN=FGA PE=1 SV=2 58 11 P08603 CFAH_HUMAN Complement factor H OS=Homo sapiens GN=CFH PE=1 SV=4 56 12 P02787 TRFE_HUMAN Serotransferrin OS=Homo sapiens GN=TF PE=1 SV=3 54 13 P00747 PLMN_HUMAN Plasminogen OS=Homo sapiens GN=PLG PE=1 SV=2 48 14 P02679 FIBG_HUMAN Fibrinogen gamma chain OS=Homo sapiens GN=FGG PE=1 SV=3 47 15 P01871 IGHM_HUMAN Ig mu chain C region OS=Homo sapiens GN=IGHM PE=1 SV=3 41 16 P04003 C4BPA_HUMAN C4b-binding protein alpha chain OS=Homo sapiens GN=C4BPA PE=1 SV=2 37 17 Q9Y6R7 FCGBP_HUMAN IgGFc-binding protein OS=Homo sapiens GN=FCGBP PE=1 SV=3 30 18 O43866 CD5L_HUMAN CD5 antigen-like OS=Homo
  • Mirna Regulons Associated with Synaptic Function

    Mirna Regulons Associated with Synaptic Function

    miRNA Regulons Associated with Synaptic Function Maria Paschou1, Maria D. Paraskevopoulou2, Ioannis S. Vlachos2, Pelagia Koukouraki1, Artemis G. Hatzigeorgiou2,3, Epaminondas Doxakis1* 1 Basic Neurosciences Division, Biomedical Research Foundation of the Academy of Athens, Athens, Greece, 2 Institute of Molecular Oncology, Biomedical Sciences Research Center ‘‘Alexander Fleming’’ Vari, Greece, 3 Department of Computer and Communication Engineering, University of Thessaly, Volos, Greece Abstract Differential RNA localization and local protein synthesis regulate synapse function and plasticity in neurons. MicroRNAs are a conserved class of regulatory RNAs that control mRNA stability and translation in tissues. They are abundant in the brain but the extent into which they are involved in synaptic mRNA regulation is poorly known. Herein, a computational analysis of the coding and 39UTR regions of 242 presynaptic and 304 postsynaptic proteins revealed that 91% of them are predicted to be microRNA targets. Analysis of the longest 39UTR isoform of synaptic transcripts showed that presynaptic mRNAs have significantly longer 39UTR than control and postsynaptic mRNAs. In contrast, the shortest 39UTR isoform of postsynaptic mRNAs is significantly shorter than control and presynaptic mRNAs, indicating they avert microRNA regulation under specific conditions. Examination of microRNA binding site density of synaptic 39UTRs revealed that they are twice as dense as the rest of protein-coding transcripts and that approximately 50% of synaptic transcripts are predicted to have more than five different microRNA sites. An interaction map exploring the association of microRNAs and their targets revealed that a small set of ten microRNAs is predicted to regulate 77% and 80% of presynaptic and postsynaptic transcripts, respectively.
  • RABIF/MSS4 Is a Rab-Stabilizing Holdase Chaperone Required for GLUT4 Exocytosis

    RABIF/MSS4 Is a Rab-Stabilizing Holdase Chaperone Required for GLUT4 Exocytosis

    RABIF/MSS4 is a Rab-stabilizing holdase chaperone required for GLUT4 exocytosis Daniel R. Gulbransona, Eric M. Davisa, Brittany A. Demmitta,b, Yan Ouyanga, Yihong Yec, Haijia Yua,d,1, and Jingshi Shena,1 aDepartment of Molecular, Cellular and Developmental Biology, University of Colorado, Boulder, CO 80309; bInstitute for Behavioral Genetics, University of Colorado, Boulder, CO 80309; cLaboratory of Molecular Biology, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD 20892; and dJiangsu Key Laboratory for Molecular and Medical Biotechnology, College of Life Sciences, Nanjing Normal University, Nanjing 210023, China Edited by Jennifer Lippincott-Schwartz, Howard Hughes Medical Institute, Ashburn, VA, and approved August 21, 2017 (received for review July 7, 2017) Rab GTPases are switched from their GDP-bound inactive confor- anabolic hormone insulin facilitates glucose uptake by acutely mation to a GTP-bound active state by guanine nucleotide exchange relocating GLUT4 from intracellular compartments to the cell factors (GEFs). The first putative GEFs isolated for Rabs are RABIF surface (6, 20, 21, 23). Upon the termination of insulin signaling, (Rab-interacting factor)/MSS4 (mammalian suppressor of Sec4) and GLUT4 is retrieved from the plasma membrane through endocy- its yeast homolog DSS4 (dominant suppressor of Sec4). However, tosis and returns to intracellular storage vesicles (6). Importantly, the biological function and molecular mechanism of these molecules the components of GLUT4 exocytosis are also involved in the remained unclear. In a genome-wide CRISPR genetic screen, we regulation of other exocytic pathways such as insulin secretion and isolated RABIF as a positive regulator of exocytosis.
  • Cell-Type-Specific Repression by Methyl-Cpg-Binding Protein 2 Is Biased Toward Long Genes

    Cell-Type-Specific Repression by Methyl-Cpg-Binding Protein 2 Is Biased Toward Long Genes

    The Journal of Neuroscience, September 17, 2014 • 34(38):12877–12883 • 12877 Neurobiology of Disease Cell-Type-Specific Repression by Methyl-CpG-Binding Protein 2 Is Biased toward Long Genes Ken Sugino,1,2 Chris M. Hempel,1 Benjamin W. Okaty,1 Hannah A. Arnson,1 Saori Kato,1 X Vardhan S. Dani,1 and Sacha B. Nelson1 1Department of Biology and Center for Behavioral Genomics, Brandeis University, Waltham, Massachusetts 02454, and 2Janelia Farm Research Campus, Ashburn, Virginia 20147 Mutations in methyl-CpG-binding protein 2 (MeCP2) cause Rett syndrome and related autism spectrum disorders (Amir et al., 1999). MeCP2 is believed to be required for proper regulation of brain gene expression, but prior microarray studies in Mecp2 knock-out mice using brain tissue homogenates have revealed only subtle changes in gene expression (Tudor et al., 2002; Nuber et al., 2005; Jordan et al., 2007; Chahrour et al., 2008). Here, by profiling discrete subtypes of neurons we uncovered more dramatic effects of MeCP2 on gene expression, overcoming the “dilution problem” associated with assaying homogenates of complex tissues. The results reveal misregulation of genes involved in neuronal connectivity and communication. Importantly, genes upregulated following loss of MeCP2 are biased toward longer genes but this is not true for downregulated genes, suggesting MeCP2 may selectively repress long genes. Because genes involved in neuronal connectivity and communication, such as cell adhesion and cell–cell signaling genes, are enriched among longer genes, their misregulation following loss of MeCP2 suggests a possible etiology for altered circuit function in Rett syndrome. Key words: cell adhesion; MeCP2; microarray; Rett syndrome Introduction 2011) but how mutations in MeCP2 lead to synaptic and circuit Mutations in the gene MECP2 (methyl-CpG binding protein 2) deficits is still unclear.
  • Development of Dual Reconstituted Humanized Mice for Studies of HIV-1 Neuropathogenesis

    Development of Dual Reconstituted Humanized Mice for Studies of HIV-1 Neuropathogenesis

    University of Nebraska Medical Center DigitalCommons@UNMC Theses & Dissertations Graduate Studies Spring 5-6-2017 Development of Dual Reconstituted Humanized Mice for Studies of HIV-1 Neuropathogenesis Weizhe Li University of Nebraska Medical Center Follow this and additional works at: https://digitalcommons.unmc.edu/etd Recommended Citation Li, Weizhe, "Development of Dual Reconstituted Humanized Mice for Studies of HIV-1 Neuropathogenesis" (2017). Theses & Dissertations. 182. https://digitalcommons.unmc.edu/etd/182 This Dissertation is brought to you for free and open access by the Graduate Studies at DigitalCommons@UNMC. It has been accepted for inclusion in Theses & Dissertations by an authorized administrator of DigitalCommons@UNMC. For more information, please contact [email protected]. Development of Dual Reconstituted Humanized Mice for Studies of HIV-1 Neuropathogenesis by Weizhe Li A DISSERTATION Presented to the Faculty of The Graduate College in the University of Nebraska In Partial Fulfillment of the Requirements For the Degree of Doctor of Philosophy Pharmacology and Experimental Neuroscience Under the Supervision of Professors Larisa Y. Poluektova and Howard E. Gendelman University of Nebraska Medical Center Omaha, Nebraska March, 2017 i TABLE OF CONTENTS TABLE OF CONTENTS ......................................................................................... i LIST OF FIGURES ............................................................................................... vi LIST OF TABLES ................................................................................................
  • Proteome and Phosphoproteome Analysis in TNF Long Term-Exposed Primary Human Monocytes

    Proteome and Phosphoproteome Analysis in TNF Long Term-Exposed Primary Human Monocytes

    International Journal of Molecular Sciences Article Proteome and Phosphoproteome Analysis in TNF Long Term-Exposed Primary Human Monocytes Bastian Welz 1,†, Rolf Bikker 1,†, Johannes Junemann 2,3,† , Martin Christmann 1 , Konstantin Neumann 1 , Mareike Weber 1, Leonie Hoffmeister 1, Katharina Preuß 1, Andreas Pich 2,3, René Huber 1,‡ and Korbinian Brand 1,*,‡ 1 Institute of Clinical Chemistry, Hannover Medical School, 30625 Hannover, Germany; [email protected] (B.W.); [email protected] (R.B.); [email protected] (M.C.); [email protected] (K.N.); [email protected] (M.W.); [email protected] (L.H.); [email protected] (K.P.); [email protected] (R.H.) 2 Institute of Toxicology, Hannover Medical School, 30625 Hannover, Germany; [email protected] (J.J.); [email protected] (A.P.) 3 Core Unit Proteomics, Hannover Medical School, 30625 Hannover, Germany * Correspondence: [email protected]; Tel.: +49-511-5326614 † These authors contributed equally to this work. ‡ These authors contributed equally to this work. Received: 11 February 2019; Accepted: 6 March 2019; Published: 12 March 2019 Abstract: To better understand the inflammation-associated mechanisms modulating and terminating tumor necrosis factor (TNF-)induced signal transduction and the development of TNF tolerance, we analyzed both the proteome and the phosphoproteome in TNF long term-incubated (i.e., 48 h) primary human monocytes using liquid chromatography-mass spectrometry. Our analyses revealed the presence of a defined set of proteins characterized by reproducible changes in expression and phosphorylation patterns in long term TNF-treated samples.